Average cost of multi drug-resistant tuberculosis treatment in Fiji
Fiji: Average cost of multi drug-resistant tuberculosis treatment was 700 constant 2022 US$ in 2022. ◆ Volatile
Latest (2022)
700 constant 2022 US$
Change on year
down 88.3%
World rank
68th
of 92 countries
All-time high
6,000 constant 2022 US$
in 2017
All-time low
700 constant 2022 US$
in 2018
Years of data
6
2017–2022
Average cost of multi drug-resistant tuberculosis treatment in Fiji, 2017–2022
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Fiji recorded 700 constant 2022 US$ for average cost of multi drug-resistant tuberculosis treatment in 2022. That is the lowest value across all 6 years on record.
That represents a change of down 88.3% on the previous year and down 88.3% over ten years.
Fiji ranks 68th of 92 countries on this measure, in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Fiji, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 6,000 constant 2022 US$ | — |
| 2018 | 700 constant 2022 US$ | -88.3% |
| 2019 | 6,000 constant 2022 US$ | +757.1% |
| 2020 | 6,000 constant 2022 US$ | +0.0% |
| 2021 | 6,000 constant 2022 US$ | +0.0% |
| 2022 | 700 constant 2022 US$ | -88.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 4,233 constant 2022 US$ | 700 constant 2022 US$ | 6,000 constant 2022 US$ | 3 |
| 2020s | 4,233 constant 2022 US$ | 700 constant 2022 US$ | 6,000 constant 2022 US$ | 3 |
Countries ranked near Fiji
- 65 Bolivia, Plurinational State of 753 constant 2022 US$ compare
- 66 Congo 726 constant 2022 US$ compare
- 67 Mali 709 constant 2022 US$ compare
- 69 South Sudan 682 constant 2022 US$
- 70 Venezuela, Bolivarian Republic of 674 constant 2022 US$ compare
- 71 Guinea 616 constant 2022 US$ compare
More health data for Fiji
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4425 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,339 deaths per 1,000 people (2090)
- Number of infants who die before age 1 77 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 4 (2023)
- Total tetanus - number of reported cases, per capita 0 units per person (2023)
- Diphtheria - number of reported cases, gaps filled 0 (2022)
- Diphtheria - number of reported cases, per capita 0 units per person (2022)
- Measles - number of reported cases, gaps filled 0 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Fiji?
- Average cost of multi drug-resistant tuberculosis treatment in Fiji was 700 constant 2022 US$ in 2022, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Fiji?
- The highest recorded value was 6,000 constant 2022 US$ in 2017.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Fiji?
- The lowest recorded value was 700 constant 2022 US$ in 2018.
- How does Fiji rank for average cost of multi drug-resistant tuberculosis treatment?
- Fiji ranks 68th out of 92 countries with data for 2022.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Fiji?
- Over the last ten years it is down 88.3%. The long-run trend across the full record is volatile.
- Where does this Fiji data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.